Colombia vs Oman: Access to anti-retroviral drugs, female
Colombia
77.0%
in 2023
Oman
76.0%
in 2024
Colombia rank
63rd
Oman rank
64th
Access to anti-retroviral drugs, female over time
- Colombia
- Oman
How they compare
Colombia currently reports 77.0% against 76.0% in Oman, a difference of 1.0%.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Oman ahead.
Colombia ranks 63rd and Oman ranks 64th of 141 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Colombia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.2% | 18.3% | 10.1% | Oman |
| 2010s | 52.0% | 55.5% | 3.5% | Oman |
| 2020s | 75.5% | 69.8% | 5.8% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Colombia or Oman?
- Colombia, at 77.0% against 76.0% in Oman as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Colombia and Oman?
- 1.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Oman?
- 24 years are reported by both, from 2000 to 2023.
- How do Colombia and Oman rank globally for access to anti-retroviral drugs, female?
- Colombia ranks 63rd and Oman ranks 64th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.